e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Clinical challenges in respiratory infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pneumocystis jirovecii pneumonia (PJP) in lymphoma patients, a tertiary cancer centre review.
H. Adderley (Manchester, United Kingdom), J. Syed (Manchester, United Kingdom), L. Covesmith (Manchester, United Kingdom), K. Linton (Manchester, United Kingdom)
Source:
International Congress 2018 – Clinical challenges in respiratory infection
Session:
Clinical challenges in respiratory infection
Session type:
Thematic Poster
Number:
4700
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Adderley (Manchester, United Kingdom), J. Syed (Manchester, United Kingdom), L. Covesmith (Manchester, United Kingdom), K. Linton (Manchester, United Kingdom). Pneumocystis jirovecii pneumonia (PJP) in lymphoma patients, a tertiary cancer centre review.. 4700
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Pneumocystis carinii (jiroveci) pneumonia (PCP) in ICU patients with hematological malignancies
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004
Pneumocystis jirovecii pneumonia, study of 26 cases
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Pneumocystis carinii pneumonia (PCP) in HIV negative patients
Source: Eur Respir J 2001; 18: Suppl. 33, 302s
Year: 2001
Early recurrence of
pneumocystis jiroveci
pneumonia (PCP) in two HIV-infected patients: linking infection relapse and immune reconstitution syndrome
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007
Pneumocystis jiroveci
colonisation in Turkish patients with primary pulmonary disorders
Source: Eur Respir J 2005; 26: Suppl. 49, 411s
Year: 2005
Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients
Source: Eur Respir J 2002; 20: 982-989
Year: 2002
Pneumocystis carinii pneumonia in an otherwise healthy patient
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003
Pneumocystis jirovecii pneumonia prophylaxis in non-HIV infected patients on immunosuppression; a regional cross-sectional study
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Clinical patterns of Pneumocystis Jirovecii in HIV and non-HIV patients
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients
Source: Eur Respir J 2012; 39: 971-978
Year: 2012
Usefulness of alveoloscopy in the diagnosis pf Pneumocystis jiroveci pneumonia in HIV+ patients
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Pneumocystis pneumonia in non-HIV patients. A retrospective study (2000-2007)
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008
Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
Radiological features of pneumocystis pneumonia (PCP) without HIV
Source: Annual Congress 2011 - Imaging in oncology and infectious diseases
Year: 2011
Outbreak of
pneumocystis jiroveci
pneumonia among renal transplant patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Assessement of pulmonary TB in association with pneumocystis jiroveci
Source: Annual Congress 2008 - Difficult tuberculosis cases
Year: 2008
The severity of Pneumocystis pneumonia without human immunodeficiency virus infection (non-HIV PCP) might be underestimated by conventional diagnostic rules for community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Prognosis of
pneumocystis jirovecii
pneumonia in non-HIV patients
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Pneumocystis carinii pneumonia complicating thoracic external radiotherapy for lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 73s
Year: 2004
Role of pneumocystis jiroveci in interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 557s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept